Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Xiong et al., 2005
Targeting reactive oxygen species and lipid peroxidation pathways is a viable therapeutic approach in cancer treatment [96]
Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS) in combination with paclitaxel (Pac) in patients (pts) with triple negative breast cancer (TNBC)
As researchers in Australia explore its mechanisms, understanding the foundational principles of sourcing this peptide is paramount for achieving valid and reproducible results
Estimation-based protocols drift by 1020% over multi-week timelines, turning what should be controlled research into uncontrolled dosing experiments
Patients with gout frequently have comorbid conditions that predispose to renal dysfunction and increased urate reabsorption, including hypertension and metabolic syndrome (insulin resistance) (see: Who Gets Gout?) Impaired urinary alkalinization in metabolic syndrome likely contributes to elevated risks of uric acid urolithiasis in the gout patient population
US$ 20.47
US$ 24.04
US$ 22.45
US$ 27.18
